These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 2039199)
21. Efficacy of lansoprazole in eradication of Helicobacter pylori. Takimoto T; Ido K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Kimura K J Clin Gastroenterol; 1995; 20 Suppl 2():S121-4. PubMed ID: 7594327 [TBL] [Abstract][Full Text] [Related]
22. Effect of lansoprazole on Helicobacter pylori. Lamouliatte H Clin Ther; 1993; 15 Suppl B():32-6. PubMed ID: 8205593 [TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors. Dattilo M; Figura N J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516 [TBL] [Abstract][Full Text] [Related]
24. Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19. Shimatani T; Inoue M; Kuroiwa T; Xu J; Mieno H; Nakamura M; Tazuma S Clin Pharmacol Ther; 2006 Jan; 79(1):144-52. PubMed ID: 16413249 [TBL] [Abstract][Full Text] [Related]
25. [Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy]. Tamura K; Murai M; Tanaka M; Kawano S Nihon Rinsho; 1993 Dec; 51(12):3261-6. PubMed ID: 8283644 [TBL] [Abstract][Full Text] [Related]
26. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication. Sharara AI Expert Rev Anti Infect Ther; 2005 Dec; 3(6):863-70. PubMed ID: 16307499 [TBL] [Abstract][Full Text] [Related]
27. Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test. Parente F; Sainaghi M; Sangaletti O; Imbesi V; Maconi G; Anderloni A; Bianchi Porro G Aliment Pharmacol Ther; 2002 Mar; 16(3):553-7. PubMed ID: 11876710 [TBL] [Abstract][Full Text] [Related]
28. Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection. Hazell SL; Mitchell HM; Hanna G; Daskalopoulos G Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):530-2. PubMed ID: 9272389 [TBL] [Abstract][Full Text] [Related]
29. Review article: the pharmacology of rabeprazole. Williams MP; Pounder RE Aliment Pharmacol Ther; 1999 Aug; 13 Suppl 3():3-10. PubMed ID: 10491723 [TBL] [Abstract][Full Text] [Related]
30. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro. Midolo PD; Turnidge JD; Lambert JR J Antimicrob Chemother; 1997 Mar; 39(3):331-7. PubMed ID: 9096182 [TBL] [Abstract][Full Text] [Related]
31. Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori. Isomoto H; Inoue K; Furusu H; Nishiyama H; Shikuwa S; Omagari K; Mizuta Y; Murase K; Murata I; Kohno S Helicobacter; 2003 Apr; 8(2):111-9. PubMed ID: 12662378 [TBL] [Abstract][Full Text] [Related]
32. Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers. Saitoh T; Fukushima Y; Otsuka H; Hirakawa J; Mori H; Asano T; Ishikawa T; Katsube T; Ogawa K; Ohkawa S Aliment Pharmacol Ther; 2002 Oct; 16(10):1811-7. PubMed ID: 12269976 [TBL] [Abstract][Full Text] [Related]
33. Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo. Williams MP; Usselmann B; Chilton A; Sercombe J; Nwokolo CU; Pounder RE Aliment Pharmacol Ther; 2003 Mar; 17(6):775-83. PubMed ID: 12641499 [TBL] [Abstract][Full Text] [Related]
34. Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum. Nagata K; Takagi E; Satoh H; Okamura H; Tamura T Antimicrob Agents Chemother; 1995 Oct; 39(10):2187-92. PubMed ID: 8619564 [TBL] [Abstract][Full Text] [Related]
35. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980 [TBL] [Abstract][Full Text] [Related]
36. Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method. Fera MT; Carbone M; De Sarro A; Blandino G; Riggio G; Cusumano V; De Sarro GB; Ciliberti FA Int J Antimicrob Agents; 1998 Nov; 10(4):285-9. PubMed ID: 9916902 [TBL] [Abstract][Full Text] [Related]
37. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding. Howden CW Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118 [TBL] [Abstract][Full Text] [Related]
38. The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine. van Herwaarden MA; Samsom M; van Nispen CH; Mulder PG; Smout AJ Aliment Pharmacol Ther; 1999 Jun; 13(6):731-40. PubMed ID: 10383501 [TBL] [Abstract][Full Text] [Related]
39. Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study. Gupta VK; Dhar A; Srinivasan S; Rattan A; Sharma MP Am J Gastroenterol; 1997 Jul; 92(7):1140-2. PubMed ID: 9219786 [TBL] [Abstract][Full Text] [Related]
40. Which proton pump inhibitor should we use? Williams CN Can J Gastroenterol; 1997; 11(1):29. PubMed ID: 9113794 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]